Clinical Trials

Can AI Truly Revolutionize Drug Discovery and Development?
Research & Development Can AI Truly Revolutionize Drug Discovery and Development?

The role of artificial intelligence (AI) in drug discovery and development has been a topic of increasing interest and debate, with many experts heralding its promise to transform the process by reducing time and costs significantly. Amid the excitement, however, there remain substantial challenges

Can mRNA Vaccines Revolutionize Pancreatic Cancer Treatment?
Research & Development Can mRNA Vaccines Revolutionize Pancreatic Cancer Treatment?

The groundbreaking exploration of mRNA vaccines, most notably recognized for their pivotal role in combating the COVID-19 pandemic, has far-reaching implications that extend beyond infectious disease management into the realm of oncology. Researchers at Memorial Sloan Kettering Cancer Center

Can Selective Gene Inactivation Explain Disease Variability?
Research & Development Can Selective Gene Inactivation Explain Disease Variability?

Traditionally, it is believed that each cell contains two copies of each gene, one from each parent, playing equal parts in cellular functions. This new study challenges that notion by revealing that some cells exhibit a bias and inactivate one parental gene copy over the other. This phenomenon,

New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis
Research & Development New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis

Endometriosis, a chronic and often debilitating condition affecting approximately 190 million women and teenage girls globally, has traditionally been diagnosed through a lengthy and invasive process. For years, women have had to endure intrusive procedures and lengthy waits before receiving a

Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?
Research & Development Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?

A significant breakthrough by researchers from the German Cancer Research Center (DKFZ), Heidelberg Stem Cell Institute (HI-STEM), and NCT Heidelberg in addressing breast cancer metastasis has the potential to revolutionize treatment approaches. Metastases to vital organs like the liver, lungs, or

Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279
Research & Development Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279

Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later